Clinical Trial Update: Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

This Phase 4 study evaluated the pharmacokinetic profile of continuous and diurnal subcutaneous apomorphine infusions in Parkinson's disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: Rennes University Hospital | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED